European Journal of Cancer
Volume 45, Issue 17 , Pages 3000-3007 , November 2009

The value of surveillance mammography of the contralateral breast in patients with a history of breast cancer

  • Wenli Lu

      Affiliations

    • Department of Epidemiology, University Medical Center Groningen, University of Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands
    • Department of Health Statistics, School of Public Health, Tianjin Medical University, China
    • Department of Epidemiology, Tianjin Medical University Cancer Institute and Hospital, China
    • ,
  • Michael Schaapveld

      Affiliations

    • Comprehensive Cancer Centre North-Netherlands, Groningen, The Netherlands
    • ,
  • Liesbeth Jansen

      Affiliations

    • Department of Surgery, University Medical Center Groningen, University of Groningen, The Netherlands
    • ,
  • Emad Bagherzadegan

      Affiliations

    • Department of Surgery, University Medical Center Groningen, University of Groningen, The Netherlands
    • ,
  • Marko Mirza Sahinovic

      Affiliations

    • Department of Surgery, University Medical Center Groningen, University of Groningen, The Netherlands
    • ,
  • Peter C. Baas

      Affiliations

    • Department of Surgery, Martiniziekenhuis, Groningen, The Netherlands
    • ,
  • Leo M.H.C. Hanssen

      Affiliations

    • Department of Surgery, Diaconessenhuis, Meppel, The Netherlands
    • ,
  • Hans C.J. van der Mijle

      Affiliations

    • Department of Surgery, Maatschap Heelkunde Zuid Friesland, Nije Smellinghe, Drachten, The Netherlands
    • ,
  • Jan D. Brandenburg

      Affiliations

    • Department of Surgery, University Medical Center Groningen, University of Groningen, The Netherlands
    • ,
  • Theo Wiggers

      Affiliations

    • Department of Surgery, University Medical Center Groningen, University of Groningen, The Netherlands
    • ,
  • Geertruida H. De Bock

      Affiliations

    • Department of Epidemiology, University Medical Center Groningen, University of Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel.: +31 50 3618061; fax: +31 50 3614493.

Received 6 March 2009 ,Revised 6 August 2009 ,Accepted 11 August 2009.

References 

  1. Soerjomataram I, Louwman WJ, Lemmens VE, et al. Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972–2001. Eur J Cancer. 2005;41:2331–2337
  2. Samant RS, Olivotto IA, Jackson JS, Mates D. Diagnosis of metachronous contralateral breast cancer. Breast J. 2001;7:405–410
  3. Tilanus-Linthorst MM, Bartels KC, Alves C, et al. Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients. Breast Cancer Res Treat. 2006;95:117–123
  4. Gao X, Fisher SG, Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2003;56:1038–1045
  5. Broet P, de la RA, Scholl SM, et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol. 1995;13:1578–1583
  6. Hill-Kayser CE, Harris EE, Hwang WT, Solin LJ. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation. Int J Radiat Oncol Biol Phys. 2006;66:1313–1319
  7. Khatcheressian JL, Wolff AC, Smith TJ, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24:5091–5097
  8. Grunfeld E, Dhesy-Thind S, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ. 2005;172:1319–1320
  9. ESMO. ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer. Ann Oncol 2001;12:1047–1048.
  10. Lu WL, Jansen L, Post WJ, et al. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat. 2009;114:403–412
  11. de Bock GH, Bonnema J, van der HJ, Kievit J, van d V. Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. J Clin Oncol. 2004;22:4010–4018
  12. Montgomery DA, Krupa K, Cooke TG. Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer. 2007;97:1632–1641
  13. Grunfeld E, Noorani H, McGahan L, et al. Surveillance mammography after treatment of primary breast cancer: a systematic review. Breast. 2002;11:228–235
  14. Field TS, Doubeni C, Fox MP, et al. Under utilization of surveillance mammography among older breast cancer survivors. J Gen Intern Med. 2008;23:158–163
  15. Schapira MM, McAuliffe TL, Nattinger AB. Underutilization of mammography in older breast cancer survivors. Med Care. 2000;38:281–289
  16. Doubeni CA, Field TS, Ulcickas YM, et al. Patterns and predictors of mammography utilization among breast cancer survivors. Cancer. 2006;106:2482–2488
  17. Ji J, Hemminki K. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology. Breast Cancer Res Treat. 2007;105:229–236
  18. Anttila A, Koskela J, Hakama M. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen. 2002;9:153–158
  19. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med. 2003;138:168–175
  20. Kolb TM, Lichy J, Newhouse JH. Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27, 825 patient evaluations. Radiology. 2002;225:165–175
  21. Kaas R, Hart AA, Besnard AP, Peterse JL, Rutgers EJ. Impact of mammographic interval on stage and survival after the diagnosis of contralateral breast cancer. Br J Surg. 2001;88:123–127
  22. Montgomery DA, Krupa K, Jack WJ, et al. Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer. 2007;96:1802–1807
  23. Kollias J, Evans AJ, Wilson AR, et al. Value of contralateral surveillance mammography for primary breast cancer follow-up. World J Surg. 2000;24:983–987
  24. Mellink WA, Holland R, Hendriks JH, et al. The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer. 1991;67:1844–1848
  25. Innos K, Horn-Ross PL. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2008;111:531–540
  26. Ciatto S, Miccinesi G, Zappa M. Prognostic impact of the early detection of metachronous contralateral breast cancer. Eur J Cancer. 2004;40:1496–1501
  27. Schaapveld M, Visser O, Louwman WJ, et al. The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res Treat. 2008;110:189–197
  28. Schootman M, Fuortes L, Aft R. Prognosis of metachronous contralateral breast cancer according to stage at diagnosis: the importance of early detection. Breast Cancer Res Treat. 2006;99:91–95
  29. Quan G, Pommier SJ, Pommier RF. Incidence and outcomes of contralateral breast cancers. Am J Surg. 2008;195:645–650
  30. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.. Ann Intern Med. 2002;137:347–360
  31. Paszat L, Sutradhar R, Grunfeld E, et al. Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series. Breast Cancer Res Treat. 2009;114:169–178

PII: S0959-8049(09)00611-X

doi: 10.1016/j.ejca.2009.08.007

European Journal of Cancer
Volume 45, Issue 17 , Pages 3000-3007 , November 2009

Article Tools

* Image Usage & Resolution